Effects of hENT1 siRNA on sensitivity of BTC cells to gemcitabine.

SIRT 1 siRNA-induced enhancement of chemosensitivity to cisplatin.

Tao Zhang (43681)
Ningning Rong (480280)
Juan Chen (61123)
Chengwei Zou (480281)
Haiyan Jing (480282)
Xiaolong Zhu (266562)
Wenlong Zhang (283123)

November 2013

Sensitivity curves of the H292 cell line toward cisplatin via MTT assay. Growth inhibition of SIR...

The differential expression of hCNT1 and hENT1 i n breast cancer and the possible impact on breast cancer therapy

Lane, Jane
Martin, Tracey
McGuigan, Christopher
Mason, Malcolm
Jiang, Wen

January 2010

hCNT1 and hENT1, two members of the human nucleoside transporter families, expression levels were in...

Correlation between gemcitabine chemosensitivity and basal expression of hENT1 mRNA.

Jaihwan Kim (481708)
Haeryoung Kim (3692143)
Jong-chan Lee (6091127)
Jin Won Kim (224828)
Woo Hyun Paik (481705)
Sang Hyub Lee (5047862)
Jin-Hyeok Hwang (249030)
Ji Kon Ryu (481706)
Yong-Tae Kim (249037)

December 2018

Expression of hENT1 mRNA showed a clear linear correlation with the log value of the half-maximal in...

Effects of hENT1 siRNA on gemcitabine sensitivity.

Jaihwan Kim (481708)
Haeryoung Kim (3692143)
Jong-chan Lee (6091127)
Jin Won Kim (224828)
Woo Hyun Paik (481705)
Sang Hyub Lee (5047862)
Jin-Hyeok Hwang (249030)
Ji Kon Ryu (481706)
Yong-Tae Kim (249037)

December 2018

During incubation with gemcitabine, cell proliferation at 144 h after treatment with hENT1 siRNA was...

Human equilibrative nucleoside transporter 1 (hENT1) expression as a predictive biomarker for gemcitabine chemotherapy in biliary tract cancer

Jaihwan Kim (481708)
Haeryoung Kim (3692143)
Jong-chan Lee (6091127)
Jin Won Kim (224828)
Woo Hyun Paik (481705)
Sang Hyub Lee (5047862)
Jin-Hyeok Hwang (249030)
Ji Kon Ryu (481706)
Yong-Tae Kim (249037)

December 2018

Gemcitabine is a principal chemotherapeutic agent for biliary tract cancer (BTC). Expression of huma...

Human equilibrative nucleoside transporter 1 (hENT1) expression as a predictive biomarker for gemcitabine chemotherapy in biliary tract cancer.

Jaihwan Kim
Haeryoung Kim
Jong-Chan Lee
Jin Won Kim
Woo Hyun Paik
Sang Hyub Lee
Jin-Hyeok Hwang
Ji Kon Ryu
Yong-Tae Kim

January 2018

Gemcitabine is a principal chemotherapeutic agent for biliary tract cancer (BTC). Expression of huma...

SIRT1 inhibition in pancreatic cancer models: contrasing effects in vitro and in vivo

Oon, Chern Ein
Strell, Carina
Yeong, Keng Yoon
Östman, Arne
Prakash, Jai

January 2015

Gemcitabine remains the standard treatment for pancreatic cancer, although most patients acquire res...

CHK1 and TEC knockdown and RRM1-dependent gemcitabine sensitivity.

Jun Zhou (6477)
Zhengming Chen (385056)
Agnes Malysa (385057)
Xin Li (51274)
Paula Oliveira (385058)
Yingtao Zhang (385059)
Gerold Bepler (137062)

March 2013

The H23 and MCF7 cell line systems with increased (−R1) and reduced (−shR1) RRM1 expression were ...

Gemcitabine toxicity in HEK293 cells with or without transfection of hCNT3 cDNA.

Robert J. Paproski (282968)
Sylvia Y. M. Yao (282974)
Nicole Favis (282979)
David Evans (41081)
James D. Young (282983)
Carol E. Cass (102519)
Roger J. Zemp (282985)

February 2013

(A) Inhibiting endogenous hENT proteins with 10 µM dilazep significantly increased gemcita...

hENT1 expression is predictive of gemcitabine outcome in pancreatic cancer: A systematic review.

Nordh, Stina
Ansari, Daniel
Andersson, Roland

January 2014

High human equilibrative nucleoside transporter 1 (hENT1)-expression has shown a survival benefit in...

Differential gemcitabine sensitivity in primary human pancreatic cancer cells and paired stellate cells is driven by heterogenous drug uptake and processing

Amrutkar, Manoj
Vethe, Nils Tore
Verbeke, Caroline Sophie
Aasrum, Monica
Vefferstad, Anette
Sántha, Petra
Gladhaug, Ivar Prydz

January 2020

Gemcitabine resistance in pancreatic ductal adenocarcinoma (PDAC) is attributed to cancer cell-intri...

Drug sensitivity test in BAP1 knockdown GBC cell line.

Takashi Hirosawa (5931845)
Masaharu Ishida (126995)
Kentaro Ishii (127917)
Keigo Kanehara (5931848)
Katsuyoshi Kudo (5931851)
Shinobu Ohnuma (223071)
Takashi Kamei (1800613)
Fuyuhiko Motoi (518977)
Takeshi Naitoh (518978)
Florin M. Selaru (127013)
Michiaki Unno (518981)

November 2018

Cell viability of BAP1 knocked-down GBC cell line G-415 under the agents of gemcitabine (GEM), cispl...

Randomized, Multicenter, Phase II Study of CO-101 Versus Gemcitabine in Patients With Metastatic Pancreatic Ductal Adenocarcinoma: Including a Prospective Evaluation of the Role of hENT1 in Gemcitabine or CO-101 Sensitivity.

Poplin E
Wasan H
Rolfe L
Raponi M
Ikdahl T
Bondarenko I
Davidenko I
Bondar V
Garin A
Boeck S
Ormanns S
Heinemann V
Evans TR
Andersson R
Hahn H
Picozzi V
Dicker A
Mann E
Voong C
Kaur P
Isaacson J
Allen A.
BASSI, Claudio

January 2013

Randomized, Multicenter, Phase II Study of CO-101 Versus Gemcitabine in Patients With Metastatic Pan...

Human equilibrative nucleoside transporter 1 (hENT1) levels predict response to gemcitabine in patients with biliary tract cancer (BTC)

Santini D.
Schiavon G.
Vincenzi B.
Cass C.
Vasile E.
Manazza A.
Catalano V.
Baldi G.
Rizzo S.
Giacobino A.
Chiusa L.
Caraglia M.
Russo A.
Mackey J.
Falcone A.
Tonini G.
LAI, ROBERTO

January 2011

Background and aim: Translational data suggest that nucleoside transporters, in particular human equ...

Interaction of selected kinases with RRM1-dependent gemcitabine efficacy.

Jun Zhou (6477)
Zhengming Chen (385056)
Agnes Malysa (385057)
Xin Li (51274)
Paula Oliveira (385058)
Yingtao Zhang (385059)
Gerold Bepler (137062)

March 2013

*The IC50 ratio was calculated by dividing the siRNA-specific IC50 by the control IC50. Cell line...

SIRT 1 siRNA-induced enhancement of chemosensitivity to cisplatin.

Tao Zhang (43681)
Ningning Rong (480280)
Juan Chen (61123)
Chengwei Zou (480281)
Haiyan Jing (480282)
Xiaolong Zhu (266562)
Wenlong Zhang (283123)

November 2013

Sensitivity curves of the H292 cell line toward cisplatin via MTT assay. Growth inhibition of SIR...

The differential expression of hCNT1 and hENT1 i n breast cancer and the possible impact on breast cancer therapy

Lane, Jane
Martin, Tracey
McGuigan, Christopher
Mason, Malcolm
Jiang, Wen

January 2010

hCNT1 and hENT1, two members of the human nucleoside transporter families, expression levels were in...

Correlation between gemcitabine chemosensitivity and basal expression of hENT1 mRNA.

Jaihwan Kim (481708)
Haeryoung Kim (3692143)
Jong-chan Lee (6091127)
Jin Won Kim (224828)
Woo Hyun Paik (481705)
Sang Hyub Lee (5047862)
Jin-Hyeok Hwang (249030)
Ji Kon Ryu (481706)
Yong-Tae Kim (249037)

December 2018

Expression of hENT1 mRNA showed a clear linear correlation with the log value of the half-maximal in...

Effects of hENT1 siRNA on gemcitabine sensitivity.

Jaihwan Kim (481708)
Haeryoung Kim (3692143)
Jong-chan Lee (6091127)
Jin Won Kim (224828)
Woo Hyun Paik (481705)
Sang Hyub Lee (5047862)
Jin-Hyeok Hwang (249030)
Ji Kon Ryu (481706)
Yong-Tae Kim (249037)

December 2018

During incubation with gemcitabine, cell proliferation at 144 h after treatment with hENT1 siRNA was...

Human equilibrative nucleoside transporter 1 (hENT1) expression as a predictive biomarker for gemcitabine chemotherapy in biliary tract cancer

Jaihwan Kim (481708)
Haeryoung Kim (3692143)
Jong-chan Lee (6091127)
Jin Won Kim (224828)
Woo Hyun Paik (481705)
Sang Hyub Lee (5047862)
Jin-Hyeok Hwang (249030)
Ji Kon Ryu (481706)
Yong-Tae Kim (249037)

December 2018

Gemcitabine is a principal chemotherapeutic agent for biliary tract cancer (BTC). Expression of huma...

Human equilibrative nucleoside transporter 1 (hENT1) expression as a predictive biomarker for gemcitabine chemotherapy in biliary tract cancer.

Jaihwan Kim
Haeryoung Kim
Jong-Chan Lee
Jin Won Kim
Woo Hyun Paik
Sang Hyub Lee
Jin-Hyeok Hwang
Ji Kon Ryu
Yong-Tae Kim

January 2018

Gemcitabine is a principal chemotherapeutic agent for biliary tract cancer (BTC). Expression of huma...

SIRT1 inhibition in pancreatic cancer models: contrasing effects in vitro and in vivo

Oon, Chern Ein
Strell, Carina
Yeong, Keng Yoon
Östman, Arne
Prakash, Jai

January 2015

Gemcitabine remains the standard treatment for pancreatic cancer, although most patients acquire res...

CHK1 and TEC knockdown and RRM1-dependent gemcitabine sensitivity.

Jun Zhou (6477)
Zhengming Chen (385056)
Agnes Malysa (385057)
Xin Li (51274)
Paula Oliveira (385058)
Yingtao Zhang (385059)
Gerold Bepler (137062)

March 2013

The H23 and MCF7 cell line systems with increased (−R1) and reduced (−shR1) RRM1 expression were ...

Gemcitabine toxicity in HEK293 cells with or without transfection of hCNT3 cDNA.

Robert J. Paproski (282968)
Sylvia Y. M. Yao (282974)
Nicole Favis (282979)
David Evans (41081)
James D. Young (282983)
Carol E. Cass (102519)
Roger J. Zemp (282985)

February 2013

(A) Inhibiting endogenous hENT proteins with 10 µM dilazep significantly increased gemcita...

hENT1 expression is predictive of gemcitabine outcome in pancreatic cancer: A systematic review.

Nordh, Stina
Ansari, Daniel
Andersson, Roland

January 2014

High human equilibrative nucleoside transporter 1 (hENT1)-expression has shown a survival benefit in...

Differential gemcitabine sensitivity in primary human pancreatic cancer cells and paired stellate cells is driven by heterogenous drug uptake and processing

Amrutkar, Manoj
Vethe, Nils Tore
Verbeke, Caroline Sophie
Aasrum, Monica
Vefferstad, Anette
Sántha, Petra
Gladhaug, Ivar Prydz

January 2020

Gemcitabine resistance in pancreatic ductal adenocarcinoma (PDAC) is attributed to cancer cell-intri...

Drug sensitivity test in BAP1 knockdown GBC cell line.

Takashi Hirosawa (5931845)
Masaharu Ishida (126995)
Kentaro Ishii (127917)
Keigo Kanehara (5931848)
Katsuyoshi Kudo (5931851)
Shinobu Ohnuma (223071)
Takashi Kamei (1800613)
Fuyuhiko Motoi (518977)
Takeshi Naitoh (518978)
Florin M. Selaru (127013)
Michiaki Unno (518981)

November 2018

Cell viability of BAP1 knocked-down GBC cell line G-415 under the agents of gemcitabine (GEM), cispl...

Randomized, Multicenter, Phase II Study of CO-101 Versus Gemcitabine in Patients With Metastatic Pancreatic Ductal Adenocarcinoma: Including a Prospective Evaluation of the Role of hENT1 in Gemcitabine or CO-101 Sensitivity.

Poplin E
Wasan H
Rolfe L
Raponi M
Ikdahl T
Bondarenko I
Davidenko I
Bondar V
Garin A
Boeck S
Ormanns S
Heinemann V
Evans TR
Andersson R
Hahn H
Picozzi V
Dicker A
Mann E
Voong C
Kaur P
Isaacson J
Allen A.
BASSI, Claudio

January 2013

Randomized, Multicenter, Phase II Study of CO-101 Versus Gemcitabine in Patients With Metastatic Pan...

Human equilibrative nucleoside transporter 1 (hENT1) levels predict response to gemcitabine in patients with biliary tract cancer (BTC)

Santini D.
Schiavon G.
Vincenzi B.
Cass C.
Vasile E.
Manazza A.
Catalano V.
Baldi G.
Rizzo S.
Giacobino A.
Chiusa L.
Caraglia M.
Russo A.
Mackey J.
Falcone A.
Tonini G.
LAI, ROBERTO

January 2011

Background and aim: Translational data suggest that nucleoside transporters, in particular human equ...

Interaction of selected kinases with RRM1-dependent gemcitabine efficacy.

Jun Zhou (6477)
Zhengming Chen (385056)
Agnes Malysa (385057)
Xin Li (51274)
Paula Oliveira (385058)
Yingtao Zhang (385059)
Gerold Bepler (137062)

March 2013

*The IC50 ratio was calculated by dividing the siRNA-specific IC50 by the control IC50. Cell line...

SIRT 1 siRNA-induced enhancement of chemosensitivity to cisplatin.

Tao Zhang (43681)
Ningning Rong (480280)
Juan Chen (61123)
Chengwei Zou (480281)
Haiyan Jing (480282)
Xiaolong Zhu (266562)
Wenlong Zhang (283123)

November 2013

Sensitivity curves of the H292 cell line toward cisplatin via MTT assay. Growth inhibition of SIR...

The differential expression of hCNT1 and hENT1 i n breast cancer and the possible impact on breast cancer therapy

Lane, Jane
Martin, Tracey
McGuigan, Christopher
Mason, Malcolm
Jiang, Wen

January 2010

hCNT1 and hENT1, two members of the human nucleoside transporter families, expression levels were in...

Correlation between gemcitabine chemosensitivity and basal expression of hENT1 mRNA.

Jaihwan Kim (481708)
Haeryoung Kim (3692143)
Jong-chan Lee (6091127)
Jin Won Kim (224828)
Woo Hyun Paik (481705)
Sang Hyub Lee (5047862)
Jin-Hyeok Hwang (249030)
Ji Kon Ryu (481706)
Yong-Tae Kim (249037)

December 2018

Expression of hENT1 mRNA showed a clear linear correlation with the log value of the half-maximal in...

Effects of hENT1 siRNA on sensitivity of BTC cells to gemcitabine.

Abstract

Extracted data

Effects of hENT1 siRNA on sensitivity of BTC cells to gemcitabine.

Abstract

Extracted data

Related items

Related items